Why we should not stop giving aspirin to pregnant women during the COVID‐19 pandemic

With the current outbreak and spread of the coronavirus disease 2019 (COVID‐19) worldwide many questions arise. There have been issued precautions regarding the use of anti‐inflammatory medications, including aspirin. To our knowledge, there is insufficient data to suggest an increased risk between...

Full description

Saved in:
Bibliographic Details
Published in:Ultrasound in Obstetrics & Gynecology 2020-06, Vol.55 (6), p.841-843
Main Authors: Kwiatkowski, S., Borowski, D., Kajdy, A., Poon, L. C., Rokita, W., Wielgos, M.
Format: Article
Language:English
Subjects:
Aspirin
Betacoronavirus
Coronavirus Infections
COVID-19
Female
Humans
Infant
Infant, Newborn
Letter to the Editor
Letters to the Editor
Pandemics
Pneumonia, Viral
Pregnancy
Pregnancy Outcome
SARS Virus
SARS-CoV-2
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:With the current outbreak and spread of the coronavirus disease 2019 (COVID‐19) worldwide many questions arise. There have been issued precautions regarding the use of anti‐inflammatory medications, including aspirin. To our knowledge, there is insufficient data to suggest an increased risk between prophylactic use of low‐dose aspirin and progression of COVID‐19 infection in pregnant women at risk of placental complications.
ISSN:0960-7692
1469-0705
DOI:10.1002/uog.22049